跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
亚邦利恒 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lisinopril and Hydrochlorothiazide Tablets
Approved
化学药品
Lisinopril and Hydrochlorothiazide Tablets
江苏亚邦爱普森药业有限公司
🇨🇳 National Medical Products Administration
Approval Date
May 23, 2023
Approval ID
7Leafdu3xHG
Company
江苏亚邦爱普森药业有限公司
Type
化学药品
Approval Details
Approval Id
7Leafdu3xHG
Approval Number
国药准字H20080384
Generic Name
赖诺普利氢氯噻嗪片
Generic Name En
Lisinopril and Hydrochlorothiazide Tablets
Brand Name
亚邦利恒
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含赖诺普利10mg,氢氯噻嗪12.5mg
Reg Date
2023-05-23
Company Name
江苏亚邦爱普森药业有限公司
Company Address
盐城市响水县城经济开发区
Production Company Name
江苏亚邦爱普森药业有限公司
Production Company Address
盐城市响水县城经济开发区
Company Detail Path
/organization/jiang-su-ya-bang-ai-pu-sen-yao-ye-you-xian-gong-si
Production Company Detail Path
/organization/jiang-su-ya-bang-ai-pu-sen-yao-ye-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 23, 2023
Approval ID
7Leafdu3xHG
Type
化学药品
Back to NMPA Approvals